Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for ...

Ianalumab is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma).

Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

Rapcabtagene autoleucel is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

For example, in the SLS, the baseline FVC exceeded 70% predicted in approximately half of the cohort and only 19 (13.1%) of 145 patients lost at least 10% of FVC within 1 year of treatment.

Image: Adobe Stock “The use of botulinum toxin for treatment of [Raynaud’s phenomenon ... to treat Raynaud’s syndrome secondary to scleroderma, Pang and colleagues conducted a systematic ...

Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Lower back pain can affect one's ability to move comfortably and function throughout the day. Medications, including over-the-counter (OTC) and prescription drugs, are available to manage pain and ...

Dave Coulier shared an update about his cancer treatment on the latest episode of his "Full House Rewind" podcast.

A new biotech start-up – Ouro Medicines – launched today with $120 million in funding from a Series A and a plan to develop ...